Table 1.
Characteristic | TOTAL | CBT | ACT | WL |
F value or χ² |
p |
---|---|---|---|---|---|---|
Gender (Female) | 45.98% (40/87) |
42.42% (14/33) |
48.28% (14/29) |
48.00% (12/25) |
.27 | .873 |
Age, in yearsb | 28.37 (6.76) Range: 19–44 |
29.80 (7.42) |
27.42 (5.56) |
27.64 (7.08) |
1.16 | .320 |
Education, in years | 15.04 (1.95) Range: 11–19 |
15.55 (1.82) |
15.00 (1.87) |
14.44 (2.10) |
2.36 | .100 |
Marital Status | 6.91 | .141 | ||||
Married/Cohabiting | 11.49% (10/87) |
21.21% (7/33) |
0.00% (0/29) |
12.00% (3/25) |
||
Single | 79.31% (69/87) |
69.70% (23/33) |
89.66% (26/29) |
80.00% (20/25) |
||
Other | 9.20% (8/87) |
9.09% (3/33) |
10.34% (3/29) |
8.00% (2/25) |
||
Reported race/ethnicitya | 1.02 | .602 | ||||
White | 50.57% (44/87) |
57.58% (19/33) |
48.28% (14/29) |
44.00% (11/25) |
||
Hispanic/ Latino/a | 17.24% (15/87) |
12.12% (4/33) |
17.24% (5/29) |
24.00% (6/25) |
||
African-American/ Black |
2.30% (2/87) |
3.03% (1/33) |
3.45% (1/29) |
0.00% (0/25) |
||
Asian-American/ Pacific Islander |
18.39% (16/87) |
15.15% (5/33) |
20.69% (6/29) |
20.00% (5/25) |
||
Children (1+) | 5.75% (5/87) |
9.09% (3/33) |
3.45% (1/29) |
4.00% (1/25) |
1.01 | .576 |
Social Phobia clinical severity rating (mean) |
5.59 (.97) Range: 4–7 |
5.73 (.91) |
5.45 (1.02) |
5.56 (1.00) |
.64 | .528 |
Currently on psychotropic medicationc |
32.18% (28/87) |
27.27% (9/33) |
27.59% (8/29) |
44.00% (11/25) |
2.24 | .325 |
Comorbid anxiety disorder (1+) d |
22.99% (20/87) |
27.27% (9/33) |
27.59% (8/29) |
12.00% (3/20) |
2.39 | .302 |
Comorbid depressive disorder d |
18.39% (16/87) |
15.15% (5/33) |
20.69% (6/29) |
20.00% (5/25) |
.38 | .829 |
Comorbid anxiety or depressive disorder |
22.99% (20/87) |
24.24% (8/33) |
20.69% (6/29) |
24.00% (6/25) |
.13 | .937 |
Comorbid anxiety and depressive disorder |
9.20% (8/87) |
9.09% (3/33) |
13.79% (4/29) |
4.00% (1/25) |
1.54 | .462 |
For race/ ethnicity, analyses assessed group differences in minority versus white status.
Demographic data was missing for 1 P.
Medications include SSRIs/SNRIs, other antidepressants/mood stabilizers, benzodiazepines and prn medications
Comorbidity was defined as a clinical severity rating of 4 or above on the ADIS